an individualized approach to gene analysis when PCR and MLPA results contradic by El-Maarri, O. et al.
ORIGINAL ARTICLE Genetics
Novel characterization of a breakpoint in F8: an
individualized approach to gene analysis when PCR and
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Summary. Haemophilia A is an X-linked bleeding
disorder caused by heterogeneous mutations in the F8
gene. Two inversion hotspots in intron 22 and intron
1, as well as point mutations, small insertions and
deletions in the F8 gene account for causal mutations
leading to severe haemophilia A. Rarely, novel
molecular mechanisms lead to a haemophilia A
phenotype which cannot be completely characterized
by routine molecular diagnostic methods. Here, we
characterized the molecular abnormality in a boy with
a severe haemophilia A phenotype. On investigation
by PCR and DNA sequencing, exon 18 of F8
repeatedly failed to amplify. However, analysis by
multiplex ligation-dependent probe amplification
demonstrated the presence of exon 18 sequence,
suggesting a more complex rearrangement than a
single exon deletion. The analysis of exon 18 and its
flanking regions by inverse PCR revealed a complex
mutation comprising insertions of extragenic
sequences from Xq28 along with a partial duplication
of exon 18. Based on the successful analysis and
characterization of the familial breakpoint, we
developed a PCR-based diagnostic approach to detect
this defect in family members in whom no diagnostic
test could be offered until this time.
Keywords: breakpoint, gene rearrangement, haemophilia
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Introduction
To date, a wide range of mutations, scattered through-
out the coding and non-coding sequence of F8, have
been reported that lead to a qualitative or quantitative
defect of the FVIII protein. The most common F8
mutations leading to a severe phenotype are inversions
[1–3]. Other mutations leading to a severe phenotype
are mainly point mutations (missense, nonsense and
splice site mutations) and, less frequently, deletions,
insertions and duplications [4,5]. Most of these muta-
tions are identified using routine PCR-based analysis
methods [6] and multiplex ligation-dependent probe
amplification (MLPA) [7,8]. Rarely, novel molecular
mechanisms lead to a haemophilia A phenotype which
cannot be completely characterized by routine molecu-
lar diagnostic methods and require an individualized
research approach to investigate fully.
Here, we present the molecular mechanism leading
to severe haemophilia A in a patient resulting from a
complex rearrangement within the genomic region of
F8. Upon investigation by PCR and MLPA, apparently
contradictory results for exon 18 of F8 were obtained.
Although the amplification of F8 repeatedly failed, the
analysis by MLPA demonstrated the presence of exon
18 sequence, suggesting a more complex mutational
event than just a single exon deletion. The subsequent
inverse PCR analysis of the non-amplifiable exon and
its flanking regions revealed a complex mutation com-
prising insertions of sequences of large non-coding
regions at Xq28 into the F8 gene along with a small
duplication of 99 bp of exon 18.
The breakpoint in the F8 gene was fully character-
ized by this investigation, and a diagnostic PCR was
established to analyse the carrier status of family
members. In addition, we present a straightforward
strategy to investigate inconsistent results of PCR
and MLPA that facilitates characterization of the
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breakpoint junctions to establish a short range PCR
for diagnostic purposes.
Materials and methods
Patient profile
The index patient is a 10-year-old boy with severe
haemophilia A and no family history of haemophilia.
Genomic DNA from the patient and potential carriers
of haemophilia in the family were extracted from
peripheral blood leucocytes using a standard salting-
out precipitation procedure. The family gave written
informed consent in accordance with the Declaration
of Helsinki.
Mutation analysis
For the molecular diagnosis of the index patient,
intron 1 and intron 22 inversions were initially
excluded. All 26 exons and adjacent intronic regions
of F8 were then amplified using standard PCR condi-
tions and MLPA was carried out using the F8 MLPA
kit P178 (MRC Holland, Amsterdam, The Nether-
lands) according to the manufacturer’s instructions.
Exon dosage was calculated using Coffalyser.Net soft-
ware (MRC Holland). The PCR using the partial
sequences of MLPA probe for verification of the
MLPA results was carried out using the primers listed
in Table S1, A. Long range (LR)-PCR was performed
to amplify the region flanking exons 15–22 using the
primers listed in Table S1, B as described earlier [9].
Inverse PCR amplification and cloning of the PCR
products
To characterize the breakpoint junctions, an inverse
PCR approach was designed and carried out as previ-
ously described [9] by digesting 1 lg of genomic DNA
with HindIII (New England Biolabs, Frankfurt, Ger-
many). Primers used for amplification are listed in
Table S1; C. Sequences were assembled and analysed
using Geneious Pro (Biomatters Ltd, Auckland, New
Zealand). Generated contigs were annotated against
assembly Build: hg19 NCBI.
Junction-specific diagnostic PCR
To establish the carrier status of family members, a
simple diagnostic PCR was designed using a primer
set amplifying across the junctions of the breakpoint
(Table S1, D). PCR was performed using the follow-
ing conditions: 15-min initial denaturation at 92°C,
35 cycles at 92°C for 30 s, 62°C for 30 s and 72°C
for 1 min using HOT FIREPol DNA Polymerase
(Solis BioDyne, Tartu, Estonia).
Results
Identification of a breakpoint in exon 18 of the F8
gene
The patient was initially investigated and found to be
negative for both the intron 1 and intron 22 F8 gene
inversions (data not shown). Subsequent amplification
(a) (b)
(c) (d)
Fig. 1. Identification of a breakpoint in exon 18 of the F8 gene. (a) PCR gel of amplification of exon 18. The amplification failed for the patient using prim-
ers located in intronic regions flanking exon 18 of F8. (b) Multiplex ligation-dependent probe amplification (MLPA) result showing normal copy number of
all exons of the F8 gene. The arrow indicates the presence of exon 18. (c) Upper panel: schematic presentation of the amplified region flanking exon 18 using
the MLPA probe as primers (red arrows: MLPA-F/R). Lower panel: PCR gel of the successful amplification of exon 18 in two fragments. (d) Upper panel:
schematic presentation of the amplified region showing the relative position of LR-PCR primers. Lower panel: PCR gel of LR-PCR across exon 18 using prim-
ers in intron 14 and intron 22 of F8. LR-PCR reveals no amplification for patient confirming the presence of a breakpoint (Cen., centromere; Tel., telomere).
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and complete sequencing of all other F8 exons
revealed no mutations but amplification of exon 18 of
F8 repeatedly failed (Fig. 1a), predicting the deletion
of exon. However, subsequent MLPA analysis, carried
out for verification of the deletion, showed normal
copy number for all exons of F8 including exon 18
(Fig. 1b). Based on this result, a more complex rear-
rangement than a single exon deletion was hypothe-
sized.
To further investigate the causal mutation, we used
the sequence information at the site of ligation of the
probe (supplied in the MLPA kit). These sequences
located within exon 18 were used to design primers
for amplification of exon 18 in two fragments. Inter-
estingly, this PCR approach resulted in successful
amplification of exon 18 (Fig. 1c) and subsequent
sequencing of the PCR fragments showed no changes
in exon 18, suggesting that a breakpoint within exon
18 resulted from a large insertion or inversion. The
next step for verification of the breakpoint involved
LR-PCR using primers of a 10.611 bp region located
between intron 14 and intron 22 (chrX: 154, 134,
911–154, 124, 301; hg19). The inability to amplify
this region flanking exon 18 of F8 in the patient con-
firmed the presence of a genomic breakpoint in this
area (Fig. 1d).
Characterization of the breakpoint junctions reveals
insertion of extragenic sequences originating from
Xq28
To characterize the breakpoint junctions, an inverse
PCR approach was designed to amplify the regions
upstream and downstream of exon 18 of the F8
gene (Fig. 2a). The genomic DNA of the index
patient and a healthy male control was digested
using the HindIII enzyme. Subsequently, the purified
ligated products were amplified using primers
located upstream and downstream of the breakpoint,
and the PCR fragments were sequenced for both
patient and the healthy control. As expected for the
control DNA, both primer pairs are embedded in
the same restriction domain and therefore they
should give the same size products. In contrast for
the patient, due to the rearrangement, additional
restriction site(s), lying asymmetrically from the ori-
ginal two restriction sites, become available. Amplifi-
cation of these new ligated products leads to
different altered size of the products compared to
that of the wild type.
The upstream inverse PCR revealed a smaller PCR
product than the control (1771 bp compared to the
2725 bp, Fig. 2b, upper panel). Sequencing of the
patient’s amplicon revealed a break within exon 18 of
(a)
(c)
(b)
Fig. 2. Inverse PCR approach for characterization of the breakpoint. (a) Relative positions of the primers in the upstream and downstream inverse PCRs
together with the surrounding HindIII cutting sites. PCR gels of the upstream and downstream inverse PCRs are shown in (b) upper and lower panel respec-
tively; additionally, the maps of breakpoints are shown in the lower panels. (c) Possible genomic organization of F8 gene after insertion within exon 18. All
genomic positions are according to hg19 (Yellow Box: L1 repeat insertion; Cen., centromere; Tel., telomere).
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the F8 gene (chrX: 154, 132, 278, c.5933; hg19)
joined with a short repetitive element of the L1 family
of repeats (chrX: 154, 474, 460–154, 474, 686; hg19)
followed by a non-coding sequence of Xq28 located
distal to F8 genomic region (chrX: 154, 473, 718–
154, 474, 696; hg19) (Fig. 2b, upper panel; Fig. S1a).
On the other hand, the downstream inverse PCR
revealed a fragment of 3362 bp, which is larger in size
compared to the product obtained from a healthy con-
trol (2819 bp) (Fig. 2b, lower panel). Sequencing of
the aberrant PCR product revealed an insertion of
non-coding sequences located at Xq28 region (chrX:
154, 487, 749–154, 486, 661; hg19) in intron 17 of
F8 at c.5998-38 (Fig. 2b; lower panel, Fig. S1b).
The sequence information obtained from the inverse
PCR clarified both the reason for the failure of the
amplification of exon 18 as well as the reason for the
positive MLPA. Firstly, the routine primers (located in
intron 17 and intron 18 of F8) cannot amplify due to
the insertions within exon 18 of F8. Secondly, the
results of sequencing the downstream PCR demon-
strate the presence of an intact exon 18, explaining
the positive MLPA (Fig. 2c, Fig. S1c), and as the
duplication consists of only part of the probe hybridis-
ing sequence of exon 18, the MLPA probe is unable
to detect this duplication (breakpoint is at c. 5933
and MPLA probe starts at c.5897 and ends at c.5964)
and will give a normal result. These findings confirm
disruption of the F8 gene within intron 17 and are
consistent with the severe haemophilia A phenotype.
Moreover, the two breakpoint junctions within F8
were characterized, but the exact arrangement of the
inserted regions on the X chromosome and the molec-
ular mechanisms leading to this mutational event
remain elusive.
Establishing a multiplex PCR for detection of the
rearrangement
Using the sequence information revealed after charac-
terization of the breakpoints, a simple multiplex short
PCR was designed to provide a diagnostic test for
detection of the breakpoint in other family members
(Fig. 3a). The amplification was done using a forward
primer in intron 17 of F8 (MPX-F8-F) with two
reverse primers, one amplifying the wild-type F8
sequence located in intron 18 of F8 (MPX-F8-R) and
one located in the inserted fragment in the genomic
region of F8 (MPX-R2) (Fig. 3b). The PCR products
of wild type and mutant regions differ in size; 450
and 603 bp respectively. All the available potential
carrier members of the family (Fig. 3c) were tested
and their carrier status was determined using the mul-
tiplex PCR (Fig. 3d).
(a)
(c) (d)
(b)
Fig. 3. Diagnostic multiplex PCR for detection of the breakpoint. (a) PCR gel of the diagnostic PCR with (b) schematic representation of the amplification
with relative positions of the primers (Yellow Box: L1 repeat insertion; Cen., centromere; Tel., telomere). (c) Pedigree of the patient with (d) the picture of the
diagnostic PCR carried out for all the carriers of the family (red arrow indicates the index patient).
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Discussion and conclusions
In majority of patients suffering from a severe haemo-
philia A phenotype, the causative mutation is detect-
able after applying the haemophilia A diagnostic flow
chart [6]. Rarely, novel molecular mechanisms lead to
a haemophilia A phenotype which cannot be com-
pletely characterized by routine molecular diagnostic
methods. Among others, mutations deep in introns
[10,11], insertions associated with deletions [12–14]
and deletions arising from both unequal homologous
recombination between Alu-derived sequences [15,16]
and non-homologous recombination [17] have been
reported.
In the present case, a simple deletion of exon 18 was
initially thought to be the causal F8 mutation leading
to haemophilia A. However, contradictory results were
obtained following MLPA analysis, and therefore an
individualized research approach was required to eluci-
date the exact genetic cause. The results shown in this
work highlight an important aspect that needs to be
taken into consideration when performing genetic
analysis of haemophilia A, namely, the importance of
implementing complementary methods in a routine
diagnostic workflow to confirm the deletion of one or
more exons in cases of unsuccessful PCR amplification.
This report demonstrates the limitations of both
PCR and MLPA applications resulting in inconsistent
results. In the present case, the failure of the amplifi-
cation is easily explicable by the F8 gene insertion.
However, the finding of the positive MLPA result has
led to two important developments. Firstly, the imple-
mentation of MLPA for the verification of the PCR
failure led to the design of an individualized diagnos-
tic approach, which could then be used for diagnosis
of carrier status. Secondly, our results show that
partial duplication of exons can be easily missed
depending on the position of the probe, for definite
exclusion of duplications and to a lesser extent dele-
tions, the availability of several probes for each exon
could avoid false-positive and false-negative results. In
the future, application of new technologies such as
next-generation sequencing would advance the genetic
analysis in haemophilia A and could facilitate faster
and easier detection of such duplications and could
provide simultaneous characterization of the break-
point junctions.
In summary, we have identified and characterized a
novel breakpoint in F8 gene leading to a severe hae-
mophilia A phenotype. Moreover, a specific PCR test
was established for family carrier detection and prena-
tal diagnosis of the rearrangement. We provide a
straight forward protocol for cases where inconsistent
results are obtained from PCR and MLPA; comprising
a simple general strategy using inverse PCR for char-
acterization of breakpoint and a multiplex PCR for
simple diagnostic analysis purposes.
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Supporting Information
Additional Supporting Information may be
found in the online version of this article:
Figure S1. Sequencing results of the
upstream and downstream inverse PCR
products of the patient. (a) Sequence align-
ment of exon 18 of F8 boxed in blue in the
genomic sequence and patient’s sequence.
The inserted regions in patient’s genomic
DNA starts with the L1M1 repeat insertion
(yellow box) followed by the inserted region
from Xq28 (chrX: 154, 473, 718; hg19) in
red box. (b) Sequence alignment of the
downstream PCR showing the intact exon
18 of F8 boxed in blue in F8 genomic
sequence and patient’s sequence. The break-
point is located in intron 17 at position
chrX: 154, 132, 401; hg19. (c) Sequence
information of genomic region of exon 18
and its flanking intronic sequences. Exons
and introns are in capital and lower case let-
ters respectively. The MLPA probes are
marked in green and red for the LPO and
RPO (50 and the 30 half of the MLPA probe)
respectively. The breakpoint within exon 18
is shown as bold and italic letters. The yel-
low marked sequences are the diagnostic
primers for amplification of exon 18.
Table S1. Primers used for characterization
of the breakpoint.
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